PICOT is a molecule which binds to anamorsin

Biochemical and Biophysical Research Communications

Volumn 408, Issue 2, 2011, Pages 329-333

  Saito, Yuri ^a   Shibayama, Hirohiko ^a   Tanaka, Hirokazu ^a   Tanimura, Akira ^a   Matsumura, Itaru ^b   Kanakura, Yuzuru ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Anamorsin; Embryogenesis; Fe S cluster protein; PICOT; Yeast two hybrid assay

Indexed keywords

ANAMORSIN; APOPTOSIS INHIBITOR; CARRIER PROTEINS AND BINDING PROTEINS; CYTOKINE; IRON SULFUR PROTEIN; PKCTHETA INTERACTING COUSIN OF THIOREDOXIN; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ARTICLE; CELL GROWTH; CELL LYSATE; CELL PROLIFERATION; EMBRYO; EMBRYO DEVELOPMENT; GROWTH INHIBITION; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; WESTERN BLOTTING;

ANIMALS; CARRIER PROTEINS; CELL LINE; EMBRYONIC DEVELOPMENT; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; IRON-SULFUR PROTEINS; MICE; MICE, MUTANT STRAINS; TISSUE DISTRIBUTION; TWO-HYBRID SYSTEM TECHNIQUES;

MUS;

EID: 79955665021     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.04.033     Document Type: Article

References (19)

1. Shibayama H., Takai E., Matsumura I., Kouno M., Morii E., Kitamuara Y., Takeda J., Kanakura Y. Identification of a cytokine-induced antiapoptotic molecule anamorsin essential for definitive hematopoiesis. J. Exp. Med. 2004, 199:581-592.
2. Mantel C., Guo Y., Lee M.R., Kim M.-K., Han M.-K., Shibayama H., Fukuda S., Yoder M.C., Pelus L.M., Kim K.-S., Broxmeyer H.E. Checkpoint-apoptosis uncoupling in human and mouse embryonic stem cells: a source of karyotypic instability. Blood 2007, 109:4518-4527.
3. Li X., Wu K., Fan D. CIAPIN1 as a therapeutic target in cancer. Expert Opin. Ther. Targets 2010, 14:1-8.
4. Li X., Pan Y., Fan R., Jin H., Han S., Liu J., Wu K., Fan D. Adenovirus-delivered CIAPIN1 small interfering RNA inhibits HCC growth in vitro and in vivo. Carcinogenesis 2008, 29:1587-1593.
5. Hao Z., Li X., Qiao T., Du R., Hong L., Fan D. CIAPIN1 confers multidrug resistance by upregulating the expression of MDR-1 and MRP-1 in gastric cancer cells. Cancer Biol. Ther. 2006, 5:261-266.
6. Li X., Hong L., Zhao Y., Jin H., Fan R., Du R., Xia L., Luo G., Fan D. A new apoptosis inhibitor, CIAPIN1 (cytokine-induced apoptosis inhibitor 1), mediates multidrug resistance in leukemia cells by regulating MDR-1, Bcl-2, and Bax. Biochem. Cell Biol. 2007, 85:741-750.
7. Shizusawa T., Shibayama H., Murata S., Saitoh Y., Sugimoto Y., Matsumura I., Ogawa H., Sugiyama H., Fukuhara S., Hino M., Kanamara A., Yamauchi A., Aozasa K., Kanakura Y. The expression of anamorsin in diffuse large B cell lymphoma: possible prognostic biomarker for low IPI patients. Leuk. Lymphoma 2008, 49:113-121.
8. He L., Wang H., Jin H., Guo C., Xie H., Yan K., Li X., Shen Q., Qiao T., Chen G., Chai N., Zhao L., Dong Q., Zheng Y., Liu J., Fan D. CIAPIN1 inhibits the growth and proliferation of clear cell renal cell carcinoma. Cancer Lett. 2009, 276:88-94.
9. Sugiyama T., Furuya A., Monkawa T., Yamamoto-Hino M., Satoh S., Ohmori K., Miyawaki A., Hanai N., Mikoshiba K., Hasegawa M. Monoclonal antibodies distinctively recognizing the subtypes of inositol 1,4,5-trisphosphate receptor: application to the studies on inflammatory cells. FEBS Lett. 1994, 354:149-154.
10. Ohayon A., Babichev Y., Pasvolsky R., Dong G., Sztarkier I., Benharroch D., Altman A., Isakov N. Hodgkin's lymphoma cells exhibit high expression levels of the PICOT protein. J. Immunotoxicol. 2010, 7:8-14.
11. Witte S., Villalba M., Bi K., Liu Y., Isakov N., Altman A. Inhibition of the c-Jun N-terminal kinase/AP-1 and NF-kB pathways by PICOT, a novel protein kinase C-interacting protein with a thioredoxin homology domain. J. Biol. Chem. 2000, 275:1902-1909.
12. Cha H., Kim J.M., Oh J.G., Jeong M.H., Park C.S., Park J., Jeong H.J., Park B.K., Lee Y.-H., Jeong D., Yang D.K., Bernecker O.Y., Kim D.H., Hajjar R.J., Park W.J. PICOT is a critical regulator of cardiac hypertrophy and cardiomyocyte contractility. J. Mol. Cell. Cardiol. 2008, 45:796-803.
13. Sheftel A., Stehling O., Lill R. Iron-sulfur proteins in health and disease. Trends Endocrinol. Metab. 2009, 21:302-314.
14. Ye H., Rouault T.A. Human iron-sulfur cluster assembly, cellular iron homeostasis, and disease. Biochemistry 2010, 49:4945-4956.
15. Zhang Y., Lyver E.R., Nakamaru-Ogiso E., Yoon H., Amutha B., Lee D.-W., Bi E., Ohnishi T., Daldal F., Pain D., Dancis A. Dre2, a conserved eukaryotic Fe/S cluster protein, functions in cytosolic Fe/S biogenesis. Mol. Cell. Biol. 2008, 28:5569-5582.
16. Haunhorst P., Berndt C., Eitner S., Godoy J.R., Lillig C.H. Characterization of the human monothiol glutaredoxin 3 (PICOT) as iron-sulfur protein. Biochem. Biophys. Res. Commun. 2010, 394:372-376.
17. Muhlenhoff U., Molik S., Godoy J.R., Uzarska M.A., Richter N., Seubert A., Zhang Y., Stubbe J., Pierrel F., Herrero E., Lillig C.H., Lill R. Cytosolic monothiol glutaredoxins function in intracellular iron sensing and trafficking via their bound iron-sulfur cluster. Cell Metab. 2010, 12:373-385.
18. Christoffersen T., Guren T.K., Spindler K.-L.G., Dahl O., Lonning P.E., Gjertsen B.T. Cancer therapy targeted at cellular signal transduction mechanisms: strategies, clinical results, and unresolved issues. Eur. J. Pharmacol. 2009, 625:6-22.
19. Ciavarella S., Milano A., Dammacco F., Silvestris F. Targeted therapies in cancer. Biodrugs 2010, 24:77-88.